Sandra Anne Banack

Sandra Anne Banack

Auto-generated profile, based on publicly available information

Sandra Anne Banack

The Institute for Ethnomedicine/PO Box 3464, Jackson, WY 83001, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2010 in Toxins
Verified
Journal Article
Open access
PDF file
SBSandra A. Banack
Sandra A. Banack
TCTracie Caller
Tracie Caller
ESElijah W. Stommel
Elijah W. Stommel
There is mounting evidence to suggest that environmental factors play a major role in the development of neurodegenerative diseases like ALS (Amyotrophic Lateral Sclerosis). The non-protein amino acid beta-N-methylamino-L-alanine (BMAA) was first associated with the high incidence of Amyotrophic Lateral Sclerosis/Parkinsonism Dementia Complex (ALS/PDC) in Guam, and has been implicated as a potential environmental factor in ALS, Alzheimer’s disease, and other neurodegenerative diseases. BMAA has a number of toxic effects on motor neurons including direct agonist action on NMDA and AMPA receptors, induction of oxidative stress, and depletion of glutathione. As a non-protein amino acid, there is also the strong possibility that BMAA could cause intraneuronal protein misfolding, the hallmark of neurodegeneration. While an animal model for BMAA-induced ALS is lacking, there is substantial evidence to support a link between this toxin and ALS. The ramifications of discovering an environmental trigger for ALS are enormous. In this article, we discuss the history, ecology, pharmacology and clinical ramifications of this ubiquitous, cyanobacteria-derived toxin.

1 October 2014
Verified
Book Chapter
Closed access
TCTracie Caller
Tracie Caller
ESElijah W. Stommel
Elijah W. Stommel
PHPatricia L. Henegan
Patricia L. Henegan
SBSandra Anne Banack
Sandra Anne Banack